Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects

All glucokinase gene mutations identified to date have been localized to exons that are common to the pancreatic and hepatic isoforms of the enzyme. While impaired insulin secretion has been observed in glucokinase-deficient subjects the consequences of this mutation on hepatic glucose metabolism re...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 98; no. 8; pp. 1755 - 1761
Main Authors Velho, G, Petersen, K F, Perseghin, G, Hwang, J H, Rothman, D L, Pueyo, M E, Cline, G W, Froguel, P, Shulman, G I
Format Journal Article
LanguageEnglish
Published United States 15.10.1996
Subjects
Online AccessGet full text

Cover

Loading…
Abstract All glucokinase gene mutations identified to date have been localized to exons that are common to the pancreatic and hepatic isoforms of the enzyme. While impaired insulin secretion has been observed in glucokinase-deficient subjects the consequences of this mutation on hepatic glucose metabolism remain unknown. To examine this question hepatic glycogen concentration was measured in seven glucokinase-deficient subjects with normal glycosylated hemoglobin and 12 control subjects using 13C nuclear magnetic spectroscopy during a day in which three isocaloric mixed meals were ingested. The relative fluxes of the direct and indirect pathways of hepatic glycogen synthesis were also assessed using [1-13C]glucose in combination with acetaminophen to noninvasively sample the hepatic UDP-glucose pool. Average fasting hepatic glycogen content was similar in glucokinase-deficient and control subjects (279+/-20 vs 284+/-14 mM; mean+/-SEM), and increased in both groups after the meals with a continuous pattern throughout the day. However, the net increment in hepatic glycogen content after each meal was 30-60% lower in glucokinase-deficient than in the control subjects (breakfast, 46% lower, P < 0.02; lunch, 62% lower, P = 0.002; dinner; 30% lower, P = 0.04). The net increment over basal values 4 h after dinner was 105 +/-18 mM in glucokinase-deficient and 148+/-11 mM in control subjects (P = 0.04). In the 4 h after breakfast, flux through the gluconeogenic pathway relative to the direct pathway of hepatic glycogen synthesis was higher in glucokinase-deficient than in control subjects (50+/-2% vs 34+/-5%; P = 0.038). In conclusion glucokinase-deficient subjects have decreased net accumulation of hepatic glycogen and relatively augmented hepatic gluconeogenesis after meals. These results suggest that in addition to the altered beta cell function, abnormalities in liver glycogen metabolism play an important role in the pathogenesis of hyperglycemia in patients with glucokinase-deficient maturity onset diabetes of young.
AbstractList All glucokinase gene mutations identified to date have been localized to exons that are common to the pancreatic and hepatic isoforms of the enzyme. While impaired insulin secretion has been observed in glucokinase-deficient subjects the consequences of this mutation on hepatic glucose metabolism remain unknown. To examine this question hepatic glycogen concentration was measured in seven glucokinase-deficient subjects with normal glycosylated hemoglobin and 12 control subjects using 13C nuclear magnetic spectroscopy during a day in which three isocaloric mixed meals were ingested. The relative fluxes of the direct and indirect pathways of hepatic glycogen synthesis were also assessed using [1-13C]glucose in combination with acetaminophen to noninvasively sample the hepatic UDP-glucose pool. Average fasting hepatic glycogen content was similar in glucokinase-deficient and control subjects (279+/-20 vs 284+/-14 mM; mean+/-SEM), and increased in both groups after the meals with a continuous pattern throughout the day. However, the net increment in hepatic glycogen content after each meal was 30-60% lower in glucokinase-deficient than in the control subjects (breakfast, 46% lower, P < 0.02; lunch, 62% lower, P = 0.002; dinner; 30% lower, P = 0.04). The net increment over basal values 4 h after dinner was 105 +/-18 mM in glucokinase-deficient and 148+/-11 mM in control subjects (P = 0.04). In the 4 h after breakfast, flux through the gluconeogenic pathway relative to the direct pathway of hepatic glycogen synthesis was higher in glucokinase-deficient than in control subjects (50+/-2% vs 34+/-5%; P = 0.038). In conclusion glucokinase-deficient subjects have decreased net accumulation of hepatic glycogen and relatively augmented hepatic gluconeogenesis after meals. These results suggest that in addition to the altered beta cell function, abnormalities in liver glycogen metabolism play an important role in the pathogenesis of hyperglycemia in patients with glucokinase-deficient maturity onset diabetes of young.
All glucokinase gene mutations identified to date have been localized to exons that are common to the pancreatic and hepatic isoforms of the enzyme. While impaired insulin secretion has been observed in glucokinase-deficient subjects the consequences of this mutation on hepatic glucose metabolism remain unknown. To examine this question hepatic glycogen concentration was measured in seven glucokinase-deficient subjects with normal glycosylated hemoglobin and 12 control subjects using 13C nuclear magnetic spectroscopy during a day in which three isocaloric mixed meals were ingested. The relative fluxes of the direct and indirect pathways of hepatic glycogen synthesis were also assessed using [1-13C]glucose in combination with acetaminophen to noninvasively sample the hepatic UDP-glucose pool. Average fasting hepatic glycogen content was similar in glucokinase-deficient and control subjects (279+/-20 vs 284+/-14 mM; mean+/-SEM), and increased in both groups after the meals with a continuous pattern throughout the day. However, the net increment in hepatic glycogen content after each meal was 30-60% lower in glucokinase-deficient than in the control subjects (breakfast, 46% lower, P < 0.02; lunch, 62% lower, P = 0.002; dinner; 30% lower, P = 0.04). The net increment over basal values 4 h after dinner was 105 +/-18 mM in glucokinase-deficient and 148+/-11 mM in control subjects (P = 0.04). In the 4 h after breakfast, flux through the gluconeogenic pathway relative to the direct pathway of hepatic glycogen synthesis was higher in glucokinase-deficient than in control subjects (50+/-2% vs 34+/-5%; P = 0.038). In conclusion glucokinase-deficient subjects have decreased net accumulation of hepatic glycogen and relatively augmented hepatic gluconeogenesis after meals. These results suggest that in addition to the altered beta cell function, abnormalities in liver glycogen metabolism play an important role in the pathogenesis of hyperglycemia in patients with glucokinase-deficient maturity onset diabetes of young.All glucokinase gene mutations identified to date have been localized to exons that are common to the pancreatic and hepatic isoforms of the enzyme. While impaired insulin secretion has been observed in glucokinase-deficient subjects the consequences of this mutation on hepatic glucose metabolism remain unknown. To examine this question hepatic glycogen concentration was measured in seven glucokinase-deficient subjects with normal glycosylated hemoglobin and 12 control subjects using 13C nuclear magnetic spectroscopy during a day in which three isocaloric mixed meals were ingested. The relative fluxes of the direct and indirect pathways of hepatic glycogen synthesis were also assessed using [1-13C]glucose in combination with acetaminophen to noninvasively sample the hepatic UDP-glucose pool. Average fasting hepatic glycogen content was similar in glucokinase-deficient and control subjects (279+/-20 vs 284+/-14 mM; mean+/-SEM), and increased in both groups after the meals with a continuous pattern throughout the day. However, the net increment in hepatic glycogen content after each meal was 30-60% lower in glucokinase-deficient than in the control subjects (breakfast, 46% lower, P < 0.02; lunch, 62% lower, P = 0.002; dinner; 30% lower, P = 0.04). The net increment over basal values 4 h after dinner was 105 +/-18 mM in glucokinase-deficient and 148+/-11 mM in control subjects (P = 0.04). In the 4 h after breakfast, flux through the gluconeogenic pathway relative to the direct pathway of hepatic glycogen synthesis was higher in glucokinase-deficient than in control subjects (50+/-2% vs 34+/-5%; P = 0.038). In conclusion glucokinase-deficient subjects have decreased net accumulation of hepatic glycogen and relatively augmented hepatic gluconeogenesis after meals. These results suggest that in addition to the altered beta cell function, abnormalities in liver glycogen metabolism play an important role in the pathogenesis of hyperglycemia in patients with glucokinase-deficient maturity onset diabetes of young.
Author Pueyo, M E
Shulman, G I
Rothman, D L
Petersen, K F
Perseghin, G
Hwang, J H
Cline, G W
Velho, G
Froguel, P
AuthorAffiliation INSERM U358, Hôpital Saint-Louis, Paris, France
AuthorAffiliation_xml – name: INSERM U358, Hôpital Saint-Louis, Paris, France
Author_xml – sequence: 1
  givenname: G
  surname: Velho
  fullname: Velho, G
– sequence: 2
  givenname: K F
  surname: Petersen
  fullname: Petersen, K F
– sequence: 3
  givenname: G
  surname: Perseghin
  fullname: Perseghin, G
– sequence: 4
  givenname: J H
  surname: Hwang
  fullname: Hwang, J H
– sequence: 5
  givenname: D L
  surname: Rothman
  fullname: Rothman, D L
– sequence: 6
  givenname: M E
  surname: Pueyo
  fullname: Pueyo, M E
– sequence: 7
  givenname: G W
  surname: Cline
  fullname: Cline, G W
– sequence: 8
  givenname: P
  surname: Froguel
  fullname: Froguel, P
– sequence: 9
  givenname: G I
  surname: Shulman
  fullname: Shulman, G I
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8878425$$D View this record in MEDLINE/PubMed
BookMark eNptUU1PAjEU7AGDgB78ASZ7MnJYafer7cGDwS8MykUPnprSvoXibovbXRP-vUsgRI2nl7yZeW8y00cd6ywgdEbwFSE0Gj2NJ4QwTpMO6mEckZDTmB2jvvcrjEmSpEkXdRmjLInSHnqZlGtpKtDBEtayNipYFBvlFmADv7H1ErzxgbHttlHuw1jpIdSQG2XA1sHl8-z2PYyGgW_mK1C1P0FHuSw8nO7nAL3d372OH8Pp7GEyvpmGKs54HfJ5lKRZTImMpdaSUJ5rnmnKWaQZaImp5lwRoIRBqlKNIdNKyQQg0XkW63iArnd31828BK1aM5UsxLoypaw2wkkjfiPWLMXCfYkU04zErf5ir6_cZwO-FqXxCopCWnCNF206NOYZbYnnPx8dPuwDbPHhDleV876C_MAgWGz7EIc-Wu7oD1eZus3cbS2a4h_FN6sTkEk
CitedBy_id crossref_primary_10_1016_j_ymben_2010_08_002
crossref_primary_10_1371_journal_pone_0079933
crossref_primary_10_2337_diabetes_53_12_3048
crossref_primary_10_1507_endocrj_EJ21_0526
crossref_primary_10_1016_j_molmet_2014_12_007
crossref_primary_10_1002_humu_10277
crossref_primary_10_1002_dmrr_217
crossref_primary_10_1007_s13300_019_0647_x
crossref_primary_10_1007_s00018_008_8322_9
crossref_primary_10_3389_fphys_2022_817542
crossref_primary_10_2337_diabetes_50_6_1351
crossref_primary_10_1172_JCI8673
crossref_primary_10_1016_j_molmet_2015_10_001
crossref_primary_10_1021_acs_analchem_5b01296
crossref_primary_10_2165_00024677_200403040_00007
crossref_primary_10_1016_j_tem_2022_12_007
crossref_primary_10_1016_j_trsl_2010_12_006
crossref_primary_10_1016_j_bbrc_2015_03_097
crossref_primary_10_1038_ncomms6190
crossref_primary_10_1152_ajpendo_1997_273_4_E743
crossref_primary_10_2337_db12_0827
crossref_primary_10_1097_00075197_199903000_00012
crossref_primary_10_1016_S1262_3636_07_70081_2
crossref_primary_10_3390_ijms232112910
crossref_primary_10_1016_j_ejphar_2013_06_014
crossref_primary_10_1016_j_molmet_2015_06_006
crossref_primary_10_1016_j_molmet_2024_101942
crossref_primary_10_1097_00060793_200008000_00005
crossref_primary_10_1080_ann_34_3_207_217
crossref_primary_10_2337_diabetes_51_7_2179
crossref_primary_10_1186_s11658_024_00640_3
crossref_primary_10_1016_j_tibs_2024_12_007
crossref_primary_10_1038_sj_bjp_0706848
crossref_primary_10_1590_S0100_879X1999000400008
crossref_primary_10_1016_j_cmet_2013_08_010
crossref_primary_10_1111_j_1463_1326_2007_00819_x
crossref_primary_10_2337_dc07_2017
crossref_primary_10_2337_dc14_2769
crossref_primary_10_1517_13543784_17_2_145
crossref_primary_10_1002_humu_21110
crossref_primary_10_1152_ajpendo_00530_2002
crossref_primary_10_2174_1573399816666191230114352
crossref_primary_10_1016_S0065_2571_97_00001_0
crossref_primary_10_1016_S1155_1941_06_41115_X
crossref_primary_10_1074_jbc_274_1_305
crossref_primary_10_1016_j_biopha_2012_07_002
crossref_primary_10_2337_diabetes_53_suppl_3_S48
crossref_primary_10_1016_j_diabres_2009_11_013
crossref_primary_10_1016_j_jbc_2021_100498
crossref_primary_10_3390_metabo12121223
crossref_primary_10_1042_BST0330371
crossref_primary_10_1016_S0889_8529_05_70101_8
crossref_primary_10_1002_pdi_108
crossref_primary_10_1074_jbc_275_14_10597
crossref_primary_10_1111_j_1463_1326_2004_00399_x
crossref_primary_10_7717_peerj_11929
crossref_primary_10_1038_876
crossref_primary_10_1016_j_molcel_2019_05_019
crossref_primary_10_1016_S1521_690X_03_00031_9
crossref_primary_10_1016_j_jep_2010_06_015
crossref_primary_10_1089_dia_2015_0333
crossref_primary_10_1074_jbc_M009525200
crossref_primary_10_1007_s00125_011_2238_x
crossref_primary_10_1007_s00125_008_1183_9
crossref_primary_10_1073_pnas_1921694117
crossref_primary_10_2337_diabetes_53_8_2042
crossref_primary_10_2165_00024677_200504010_00002
crossref_primary_10_1016_j_annfar_2009_02_031
crossref_primary_10_1016_j_metabol_2018_09_004
crossref_primary_10_1016_j_gene_2012_12_036
crossref_primary_10_1111_j_1365_2265_2008_03184_x
crossref_primary_10_1111_j_1651_2227_1998_tb01550_x
crossref_primary_10_1054_mehy_1997_0682
crossref_primary_10_2337_db10_1663
crossref_primary_10_1074_jbc_M213112200
crossref_primary_10_1080_14786419_2021_1931187
crossref_primary_10_1210_jc_2013_3248
crossref_primary_10_1039_C7FO01035D
crossref_primary_10_1039_C7FO00190H
crossref_primary_10_2337_db06_1660
crossref_primary_10_1074_jbc_M107001200
crossref_primary_10_2337_db10_1032
crossref_primary_10_1152_physrev_00019_2009
crossref_primary_10_14341_DM12819
crossref_primary_10_1590_S0004_27302002000200012
crossref_primary_10_1126_scitranslmed_abh1316
crossref_primary_10_1016_j_bbacli_2016_02_001
crossref_primary_10_3390_life13040946
crossref_primary_10_1016_j_diabres_2018_10_004
crossref_primary_10_1073_pnas_96_25_14511
crossref_primary_10_2337_diabetes_50_2_392
crossref_primary_10_3390_cancers12082101
crossref_primary_10_1051_medsci_20031989854
crossref_primary_10_1152_physrev_00022_2003
crossref_primary_10_1038_nrendo_2017_80
crossref_primary_10_2337_diabetes_50_3_622
crossref_primary_10_1172_JCI17975
crossref_primary_10_1074_jbc_M002427200
crossref_primary_10_1016_j_jff_2023_105534
crossref_primary_10_1053_beem_2001_0148
crossref_primary_10_1016_j_mam_2015_09_002
crossref_primary_10_1074_jbc_M107744200
crossref_primary_10_1042_BJ20080595
crossref_primary_10_1146_annurev_nutr_071715_051145
crossref_primary_10_3390_ijms22020918
crossref_primary_10_1152_physiologyonline_2000_15_4_198
crossref_primary_10_1016_j_beem_2011_12_001
crossref_primary_10_1042_BSR20160385
crossref_primary_10_2337_diabetes_51_10_3043
crossref_primary_10_1126_science_1084073
crossref_primary_10_1056_NEJMra002168
crossref_primary_10_1152_ajpendo_2000_278_1_E65
crossref_primary_10_2337_diabetes_51_1_49
crossref_primary_10_1007_s11892_002_0071_9
crossref_primary_10_1292_jvms_70_1239
crossref_primary_10_1679_aohc_63_243
crossref_primary_10_1371_journal_pone_0097139
crossref_primary_10_1016_j_pcl_2005_07_005
crossref_primary_10_1177_0004563213483458
crossref_primary_10_1073_pnas_96_22_12737
crossref_primary_10_1016_j_cmet_2013_12_001
crossref_primary_10_1016_j_ecl_2006_02_009
crossref_primary_10_2337_db11_1462
crossref_primary_10_2337_diacare_26_7_2069
crossref_primary_10_1038_nbt0302_243
crossref_primary_10_1038_953
crossref_primary_10_3181_0904_RM_126
crossref_primary_10_1016_S1043_2760_98_00134_9
crossref_primary_10_1111_1755_0998_13397
crossref_primary_10_14814_phy2_13661
crossref_primary_10_3390_ijerph19105980
crossref_primary_10_1016_j_beem_2007_07_010
crossref_primary_10_1210_er_2007_0024
crossref_primary_10_1515_JPEM_1999_12_4_487
crossref_primary_10_1016_j_diabres_2022_109779
crossref_primary_10_3389_fendo_2021_802423
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1172/JCI118974
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 1761
ExternalDocumentID PMC507613
8878425
10_1172_JCI118974
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: R01 DK-49230
– fundername: NCRR NIH HHS
  grantid: M01 RR-00123
– fundername: NIDDK NIH HHS
  grantid: P01 DK-45735
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
29K
2WC
354
3O-
53G
5GY
5RE
5RS
8F7
AAWTL
AAYOK
AAYXX
ABOCM
ABPMR
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
AEAQA
AENEX
AFCHL
AFFNX
AHMBA
AI.
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
FRP
GROUPED_DOAJ
GX1
HYE
H~9
IAO
IEA
IHR
INH
IOF
IPO
J5H
KQ8
L7B
M1P
M5~
MVM
N4W
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
OVT
P2P
P6G
RPM
TEORI
TR2
TVE
UHU
VH1
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZGI
ZXP
ZY1
~H1
CGR
CUY
CVF
ECM
EIF
INR
NPM
PKN
7X8
5PM
ID FETCH-LOGICAL-c369t-9b2456371a3adda179fd96d7982d8eda07d99c1e718e5c5d0e6dcca4ee4df63d3
ISSN 0021-9738
IngestDate Thu Aug 21 14:35:36 EDT 2025
Fri Jul 11 01:04:49 EDT 2025
Wed Feb 19 01:14:37 EST 2025
Tue Jul 01 00:54:02 EDT 2025
Thu Apr 24 22:54:07 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c369t-9b2456371a3adda179fd96d7982d8eda07d99c1e718e5c5d0e6dcca4ee4df63d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.jci.org/articles/view/118974/files/pdf
PMID 8878425
PQID 78473967
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_507613
proquest_miscellaneous_78473967
pubmed_primary_8878425
crossref_primary_10_1172_JCI118974
crossref_citationtrail_10_1172_JCI118974
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1996-10-15
1996-Oct-15
19961015
PublicationDateYYYYMMDD 1996-10-15
PublicationDate_xml – month: 10
  year: 1996
  text: 1996-10-15
  day: 15
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of clinical investigation
PublicationTitleAlternate J Clin Invest
PublicationYear 1996
References 1401068 - J Clin Invest. 1992 Oct;90(4):1323-7
2065850 - Diabetologia. 1991 Feb;34(2):67-73
8376578 - J Clin Invest. 1993 Sep;92(3):1174-80
1864968 - J Clin Invest. 1991 Aug;88(2):578-87
8325892 - J Biol Chem. 1993 Jul 15;268(20):15200-4
8446612 - Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1932-6
2682629 - Proc Natl Acad Sci U S A. 1989 Oct;86(20):7838-42
8227324 - J Clin Invest. 1993 Nov;92(5):2092-8
1532777 - Diabetes Care. 1992 Mar;15(3):318-68
8132752 - J Clin Invest. 1994 Mar;93(3):1120-30
8433729 - N Engl J Med. 1993 Mar 11;328(10):697-702
7553875 - Cell. 1995 Oct 6;83(1):69-78
8530440 - J Biol Chem. 1995 Dec 22;270(51):30253-6
2205106 - Am J Physiol. 1990 Sep;259(3 Pt 1):E335-41
1948033 - Science. 1991 Oct 25;254(5031):573-6
7665557 - J Biol Chem. 1995 Sep 15;270(37):21464-7
1502186 - Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7698-702
6472448 - Nature. 1984 Aug 23-29;310(5979):681-3
1354782 - Lancet. 1992 Aug 22;340(8817):444-8
2404717 - Diabetes Care. 1990 Jan;13(1):49-64
8203517 - Am J Physiol. 1994 May;266(5 Pt 1):E796-803
8609218 - J Clin Invest. 1996 Feb 1;97(3):642-8
8720607 - Diabetologia. 1996 Jan;39(1):82-90
2550428 - J Biol Chem. 1989 Sep 25;264(27):15936-42
1570017 - Nature. 1992 Apr 23;356(6371):721-2
2189759 - Diabetes. 1990 Jun;39(6):647-52
8349034 - Diabetes. 1993 Sep;42(9):1238-45
7860761 - J Clin Invest. 1995 Feb;95(2):783-7
8168650 - Diabetes. 1994 May;43(5):718-23
8168652 - Diabetes. 1994 May;43(5):730-3
References_xml – reference: 1354782 - Lancet. 1992 Aug 22;340(8817):444-8
– reference: 8203517 - Am J Physiol. 1994 May;266(5 Pt 1):E796-803
– reference: 1401068 - J Clin Invest. 1992 Oct;90(4):1323-7
– reference: 8227324 - J Clin Invest. 1993 Nov;92(5):2092-8
– reference: 7860761 - J Clin Invest. 1995 Feb;95(2):783-7
– reference: 2404717 - Diabetes Care. 1990 Jan;13(1):49-64
– reference: 1532777 - Diabetes Care. 1992 Mar;15(3):318-68
– reference: 2682629 - Proc Natl Acad Sci U S A. 1989 Oct;86(20):7838-42
– reference: 2189759 - Diabetes. 1990 Jun;39(6):647-52
– reference: 1570017 - Nature. 1992 Apr 23;356(6371):721-2
– reference: 1864968 - J Clin Invest. 1991 Aug;88(2):578-87
– reference: 8132752 - J Clin Invest. 1994 Mar;93(3):1120-30
– reference: 8609218 - J Clin Invest. 1996 Feb 1;97(3):642-8
– reference: 2205106 - Am J Physiol. 1990 Sep;259(3 Pt 1):E335-41
– reference: 8433729 - N Engl J Med. 1993 Mar 11;328(10):697-702
– reference: 8446612 - Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1932-6
– reference: 8530440 - J Biol Chem. 1995 Dec 22;270(51):30253-6
– reference: 8349034 - Diabetes. 1993 Sep;42(9):1238-45
– reference: 8376578 - J Clin Invest. 1993 Sep;92(3):1174-80
– reference: 1948033 - Science. 1991 Oct 25;254(5031):573-6
– reference: 7553875 - Cell. 1995 Oct 6;83(1):69-78
– reference: 8168650 - Diabetes. 1994 May;43(5):718-23
– reference: 2065850 - Diabetologia. 1991 Feb;34(2):67-73
– reference: 1502186 - Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7698-702
– reference: 6472448 - Nature. 1984 Aug 23-29;310(5979):681-3
– reference: 8168652 - Diabetes. 1994 May;43(5):730-3
– reference: 2550428 - J Biol Chem. 1989 Sep 25;264(27):15936-42
– reference: 8720607 - Diabetologia. 1996 Jan;39(1):82-90
– reference: 7665557 - J Biol Chem. 1995 Sep 15;270(37):21464-7
– reference: 8325892 - J Biol Chem. 1993 Jul 15;268(20):15200-4
SSID ssj0014454
Score 1.9701353
Snippet All glucokinase gene mutations identified to date have been localized to exons that are common to the pancreatic and hepatic isoforms of the enzyme. While...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1755
SubjectTerms Adult
Diabetes Mellitus, Type 2 - metabolism
Glucokinase - deficiency
Glucokinase - genetics
Gluconeogenesis
Humans
Insulin - blood
Liver Glycogen - biosynthesis
Male
Middle Aged
Title Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects
URI https://www.ncbi.nlm.nih.gov/pubmed/8878425
https://www.proquest.com/docview/78473967
https://pubmed.ncbi.nlm.nih.gov/PMC507613
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgCLQXxG2i4xYhHoaQIY1jJ35EA9R26njZ0HiK4kvWiJJWaysEv57jS5wUigS8RFVsOZW_LyfH9jnfQegFpwkrRcVxWuUSpzQmWAxVgmUaK8U1F5Ut5zM9ZaPzdHJBL7qarTa7ZC1eyx8780r-B1W4B7iaLNl_QDYMCjfgN-ALV0AYrn-F8Rje5doEkM_00iqvXs6_ywV0N0IE4NkZsZG6eWXD0r_UDXywsNJGMsLrjE4_vvuME7MxsNoIsyGz6vuqXdaY9VdDDmXdSXN0Z_if9Hxmd137tbrAtXRW7aQLIDYh9_py5qQLQufRN79vPfHZEspn5jFjwV0qZkgMGGKeObGW1rjyvEeivGcpwW2hu014ZiRhJ8djWPpwV8GnB-Xyq8USTKM5P-w-YiG00LdcRzcSWDjYRfb4JJwrpSn1utzur3qtKXjmm_DEfXTTD7Ltq_y2APk1jrbnmJzdQbc9QtFbR4-76Jpu7qFbUx8zcR-dtiyJPEuiliVRYElUN9FOlkRHjiMvo5YhD9D5h_dnxyPsq2hgSRhfYy7M2TbJhiWBb1kJBrhSnKmM54nKtSrjTHEuhxqcFE0lVbFmCl7rVOtUVYwocoD2mkWjH6KIER0nUjNeKpoSkZSESSoEJWVeSZqXA3TUzlchvcS8qXQyL-xSM0uKMMkD9Dx0XTpdlV2dnrWTXoDVM0dZZaMXm1UB8GSEs2yADhwEYRAP3QCxLWxCu5FT325p6pmVVadmS48c_mnER2i_Y_1jtLe-2ugn4JCuxVPLsZ-4mIv0
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impaired+hepatic+glycogen+synthesis+in+glucokinase-deficient+%28MODY-2%29+subjects&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Velho%2C+G&rft.au=Petersen%2C+K+F&rft.au=Perseghin%2C+G&rft.au=Hwang%2C+J+H&rft.date=1996-10-15&rft.issn=0021-9738&rft.volume=98&rft.issue=8&rft.spage=1755&rft_id=info:doi/10.1172%2FJCI118974&rft_id=info%3Apmid%2F8878425&rft.externalDocID=8878425
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon